News · PR

News · PR

Notice of Appointment of New Director and President

  • Press Releases

~Announcement of Appointment of New Director and President~

Bushu Pharmaceuticals Ltd. (Kawagoe City, Saitama Prefecture; hereinafter “Bushu Pharma”) is pleased to announce that Tadao Takano has been appointed President and COO, and Tetsuichi Okada has been appointed Chairman and CEO, effective June 30, 2021.

At present, Bushu Pharma is actively expanding its business, including the distribution of products in Japan and other Asian countries using Bushu Pharma as distribution hub (our “Gateway to Asia” strategy), the launch of the Bushu Pharma Packaging Center, which will provide new inspection and packaging services, and the expansion of our injectable drug business. In addition, the Company is making bold efforts to accelerate our overseas business development and to support the development of investigational drugs, strengthening our ability to provide a one-stop service from technical transfer and manufacturing to distribution.

At the same time, the environment the Company faces is undergoing a period of major change – including changes in business model -due to the prolonged spread of COVID-19 infections .

Mr. Takano joined Bushu Pharma in April 2019, providing leadership mainly in the Production Division since that time. Furthermore, from July 2019, his leadership role expanded as he took on the roles of Vice President and COO.

In order for Bushu Pharma to successfully expand its business and further promote business growth in this challenging environment, the company needs stronger leadership, strategic direction and operational guidelines, more than ever before. Taking this into consideration, Takano has been appointed as President of the Company.

All of us at Bushu Pharma are united in our determination to do our utmost to meet the diverse needs of our customers, and we will continue to contribute to society by providing superior services and solutions to our customers. We look forward to your continued support. Brief personal record of Tadao Takano, President
August 2017 – Senior Manager, Supply Chain, Astellas Amgen Biopharma K.K.
January 2019 – Head of Supply Chain, Alnylam Japan K.K.
April 2019 – Advisor, Bushu Pharmaceuticals Ltd.
July 2019 – Vice President/COO and General Manager, Supply Chain Management Division, Bushu Pharmaceuticals Ltd.
June 2021 – President and COO, Bushu Pharmaceuticals Ltd. For inquiries, please contact:
Tetsuya Morikawa, Senior Vice president and CFO
Phone: +81-49- 233-4651

Drawing on its experience and knowledge as a contract development and manufacturing organization (CDMO) it has cultivated over 20 years, Bushu Pharma manufactures solid preparations, solid preparation primary packaging, injection manufacturing, and injection packaging not only for domestic pharmaceuticals but also for global pharmaceutical manufacturers. Bushu Pharma is capable of providing a wide range of products and services — from clinical trial supplies to commercial product development support to commercialization — and has numerous manufacturing facilities and technologies.

From project start to approval, Bushu Pharma is a leading domestic contract manufacturing company that can provide optimal solutions such as technology transfer, production, packaging, and logistics in Japan.


As a company specializing in contract manufacturing of pharmaceutical drugs, we offer a wide range of contract services tailored to clients’ needs based on our extensive experience and know-how accumulated over many years.